Stocks · Healthcare · Medical - Diagnostics & Research
Insight Molecular Diagnostics Inc. IMDX
$3.44 -0.86% Close, Oct 2, 2026 · NASDAQ · Market cap $111.1M
Expensive vs sector
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to -2558.7% from -1498.3% a year earlier.
- Revenue over the last four quarters was $1.7M, down 60.8% from a year earlier, slowing from -49.3% a quarter earlier.
- The diluted share count rose 14.8% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 10%
- Revenue growth, 3-year CAGRTop 10%
- Revenue growth accelerationBottom 16%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 3%
- Gross marginBottom 10%
- Operating marginBottom 9%
- Accruals (lower is better)Top 3%
- Interest coverBottom 8%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 17%
- Free-cash-flow yieldBottom 19%
- EBITDA / enterprise valueBottom 13%
- Sales / enterprise valueBottom 12%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 50%
- 6-month returnBottom 34%
- 1-year return vs S&P 500Bottom 46%
- Distance from 52-week highBottom 17%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 13%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 29%
- Upside to consensus price targetTop 22%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 11%
- Maximum drawdown, 3 yearsTop 50%
- Beta vs S&P 500 (lower is better)Top 33%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -49.3% | -60.8% | ↓ |
| Gross margin | 54.5% | 11.2% | ↓ |
| Operating margin | -1498.3% | -2558.7% | ↓ |
| FCF margin | -556.7% | -1848.8% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -60.8% | -49.3% | ↓ | Bottom 10% |
| Gross margin | 11.2% | 54.5% | ↓ | Bottom 10% |
| Operating margin | -2558.7% | -1498.3% | ↓ | Bottom 9% |
| Net margin | -2955.6% | -1489.7% | ↓ | — |
| Free-cash-flow margin | -1848.8% | -556.7% | ↓ | — |
| Return on invested capital | -204.8% | — | Bottom 3% | |
| Revenue growth, 3-year CAGR | 61.8% | — | Top 10% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -76.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 150.8%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -1.7 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -436.0×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -22.37%
- Shareholder yield
- -22.37%
- Share count change, 1 year
- +14.8%
- Share count change, 3-year CAGR
- +65.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 1 of 8
- Average EPS surprise, last 4
- -58.3%
- Average 2-day reaction, last 8
- +0.8%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $9.75
- Target vs current price
- +183.4%
- Analysts with a rating
- 11
- Share rating Buy or Strong Buy
- 64%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 10, 2026 | -22.1% | -1.2% | -10.6% | -14.5% | — |
| May 13, 2026 | +54.1% | +2.4% | +11.6% | +15.7% | -3.0% |
| Mar 26, 2026 | -203.2% | -0.7% | -16.9% | -15.0% | +30.4% |
| Nov 10, 2025 | -61.9% | +9.0% | +18.6% | -20.8% | +7.2% |
| Aug 14, 2025 | -30.4% | -2.0% | +2.0% | +29.8% | +165.3% |
| May 12, 2025 | -9.5% | -2.1% | -2.8% | -3.1% | -7.7% |
| Mar 24, 2025 | -382.0% | -2.1% | -5.6% | -15.3% | -5.9% |
| Nov 12, 2024 | -122.7% | +3.4% | -9.3% | -13.8% | -28.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.31 | -$0.25 | -22.1% | $239,000 |
| May 13, 2026 | -$0.12 | -$0.26 | +54.1% | $32,000 |
| Mar 26, 2026 | -$0.72 | -$0.24 | -203.2% | $1.1M |
| Nov 10, 2025 | -$0.34 | -$0.21 | -61.9% | $260,000 |
| Aug 14, 2025 | -$0.30 | -$0.23 | -30.4% | $518,000 |
| May 12, 2025 | -$0.26 | -$0.24 | -9.5% | $2.1M |
| Mar 24, 2025 | -$1.93 | -$0.40 | -382.0% | $1.5M |
| Nov 12, 2024 | -$0.98 | -$0.44 | -122.7% | $115,000 |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 57.45× | — | — | Bottom 12% |
| Free-cash-flow yield | -27.80% | — | — | Bottom 19% |
| Earnings yield | -44.19% | — | — | Bottom 17% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -10.6%
- 200-day average slope (20 days)
- -3.5%
- Distance from 50-day average
- -18.2%
- Distance from 200-day average
- -32.2%
- RSI (14)
- 39.6
- Relative volume
- 1.33×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 92.7%
- Volatility vs own 5-year history
- 64th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.85
- Correlation with S&P 500
- 0.13
- Current drawdown from 1-year high
- -59.4%
- Maximum drawdown, 3 years
- -69.9%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 16, 2021 | Jan 22, 2025 | -98.5% | 988 days | Not yet recovered |
| Jan 25, 2021 | Jan 27, 2021 | -24.1% | 2 days | 7 days (Feb 5, 2021) |
| Oct 14, 2020 | Nov 2, 2020 | -16.0% | 13 days | 7 days (Nov 11, 2020) |
| Dec 16, 2020 | Dec 29, 2020 | -15.6% | 8 days | 6 days (Jan 7, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $111.1M
- EPS, diluted (TTM)
- -$1.52
- Revenue (TTM)
- $1.7M
- 52-week range
- $2.42 – $8.51
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $2.2M | $958,000 | $1.5M | $1.9M | $4.1M |
| Gross profit | $1.4M | -$18,000 | $413,000 | $740,000 | $190,000 |
| Operating income | -$53.7M | -$18.0M | -$25.1M | -$61.0M | -$30.6M |
| Net income | -$64.1M | -$72.9M | -$27.8M | -$60.7M | -$50.2M |
| EPS (diluted) | -$14.40 | -$20.00 | -$3.75 | -$4.66 | -$1.65 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $115,000 | $1.5M | $2.1M | $518,000 | $260,000 | $1.1M | $32,000 | $239,000 |
| Net income | -$13.5M | -$33.5M | -$6.7M | -$9.7M | -$10.9M | -$23.0M | -$4.3M | -$11.3M |
| EPS (diluted) | -$0.98 | -$1.93 | -$0.26 | -$0.30 | -$0.34 | -$0.75 | -$0.12 | -$0.31 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$35.9M | -$45.6M | -$23.3M | -$20.7M | -$22.2M |
| Capital expenditure | -$2.2M | -$4.3M | -$281,000 | -$516,000 | -$3.2M |
| Free cash flow | -$38.2M | -$49.9M | -$23.6M | -$21.2M | -$25.4M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $77.7M | $32.8M | $13.8M | $27.8M | $28.7M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $17.8M
- Total assets
- $29.4M
- Total liabilities
- $50.7M
- Total debt
- $2.6M
- Net debt
- -$15.1M
- Shareholders’ equity
- -$21.3M
As of Jun 30, 2026 (filed Aug 10, 2026).
Short interest
- Shares sold short
- 992,474
- Days to cover
- 4.76
- Change vs previous report
- +6.6%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jul 25, 2023
- 1-for-20